ArticleThe oncologist2019

Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial.

Carl-Henrik Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.